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in right ventricular apex, the ICD was placed in the left chest.
RESULTS All patients were successfully implanted ICD. We gave
those Postoperatives a follow-up of 3 w 12 months, no surgery related
complications happened. Among of them, there were 2 patients
launched the ICD therapy program (electric shock cardioverter, deﬁ-
brillation or ATP treatment), and the other 2 cases did not start
treatment program.
CONCLUSIONS The ICD can convert the malignant arrhythmia effec-
tively, it is a preferred treatment in the treatment of malignant
arrhythmia, and the prevention of sudden death.
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To evaluate the relational ships between heart rate changes before and
after pacemaker implantation and BNP
Shuangbin Li
Jilin City Central Hospital
OBJECTIVES To evaluate the relational ships between heart rate
changes before and after pacemaker implantation and B-type brain
natriuretic peptide (BNP) levels.
METHODS A total of 118 patients with sick sinus syndrome of DDD(R)
cardiac pacemaker therapy and 100 patients with atrial ﬁbrillation and
slow heart rate of single cavity (VVI) cardiac pacemaker therapy from
December 2007 to January 2011 were enrolled in this study. We fol-
lowed the changes of heart rate for postoperative patients and detect
the plasma BNP level with enzyme-linked immunosorbent method;
we get the change rules between the two by comparison.
RESULTS Through a median follow-up of 60 days and laboratory tests
and pacemaker programmed control, Compared with preoperative
plasma levels, the plasma BNP levels of the sick sinus syndrome who
Accept double cavity of DDD cardiac pacemaker therapy (R) declined
signiﬁcantly[ (272.1721.23) ng/L vs (52.3918.22) ng/L, P<0.01]. Atrial
ﬁbrillation with slow heart rate who accepted single cavity VVI cardiac
pacemaker therapy [(112.0311.34) ng/L vs. (103.9312.54) ng/L,
P<0.01], Compared with preoperative plasma levels, blood plasma
BNP level has no obvious changes. The relationship between heart
rate and blood plasma BNP levels were signiﬁcantly.
CONCLUSIONS Slow heart rate can increase left cardiac preload and
damage ventricular systolic function and cause cardiac insufﬁciency
for a long time.ARRHYTHMIA INTERVENTION
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Warfarin Effect on Renal function in Patients with Nonvalvular Atrial
Fibrillation: Results from the Chinese Atrial Fibrillation Registry
Yu Kong,1 Xin Du,1 Hang Li,2 Ma Chang Sheng1
1Beijing Anzhen Hospital, Capital Medical University; 2Peking Union
Medical College Hospital
OBJECTIVES Warfarin is the most commonly used oral medication for
anticoagulation to reduce the risk of stroke from atrial ﬁbrillation, but
little data is available for demonstrating its impacts on renal function
of patients with nonvalvular atrial ﬁbrillation (NVAF).
The prospective study aimed to evaluate warfarin effect on renal
function by analyzing data of a total of 1590 Chinese adult patients,
enrolled in the Chinese Atrial Fibrillation Registry, with ECG-detected
NVAF with no dialysis.
METHODS We calculated estimated glomerular ﬁltration rate (eGFR)
using the Chinese Modiﬁcation of Diet in Renal Disease study equa-
tion. Patients were divided into two groups, one group with warfarin
(n¼ 696) and the other group with no anticoagulation (n¼894 ). The
endpoint was reached with the event of a S 25% decrease in eGFR.
The results of laboratory investigations and eGFR were recorded at
months 3, 6, 12, 18, and 24 from treatment initiation.
RESULTS With follow-up over 2.7 years, comparing the two groups,
warfarin grouphas less event rate thanno anticoagulation group (8.05%
versus 12.08%, p¼0.005) and longer survival time (LogRank p¼0.020).
Additionally, in our multivariate Cox regression analysis, warfarin
therapy was discovered to be the only protective factor in these NVAF
patients (Hazard Rate 0.700 ,95% CI: 0.496-0.990, P ¼ 0.044).
CONCLUSIONS Warfarin therapy has protection effect on event of a
S25% decrease in eGFR and delays kidney function deterioration in
Chinese patients with NVAF.GW26-e1465
Self management of warfarin therapy in atrial ﬁbrillation patients in China,
a pilot study
Fan Wu, Ping Lei
Tianjin Medical University General Hospital
OBJECTIVES The objective of this study was to evaluate the impact of
a patient self-management program on security, efﬁcacy, quality of
life about anticoagulation control in AF patients requiring chronic
warfarin therapy compared with clinic standard treatment in China.
METHODS Our study was a prospective cohort study. 274 eligible sub-
jects agreed to participate. 89 subjects chose the portable INR monitor
to self-testing at home, who were assigned to PSM group. 185 subjects
received standard treatment in an anticoagulation clinic, they were
assigned to conventional group. the PSM group participated in the
consecutive instruction courses that aimed to practice OAC manage-
ment on their own. Follow-up 12 months. Quality of life (QOL) was
assessed using the questionnaire Short-Form 12 Health Survey, version
2 (SF-12v2), Time in therapeutic range (TTR) assessed the quality of the
anticoagulation treatment given. An INR range of 2.0 to 3.0 has been
established as therapeutic by stroke prevention trials in AF.
RESULTS 80 subjects in PSM group and 168 subjects in conventional
group completed the study, respectively. The two groups of data are
shown that the regression equation for measured value of the portable
INR monitor (y axis) and traditional central lab measured value (x
axis) is y ¼ 0.927x þ0.177. Good correlation between the INR
measured values of the two groups can be observed (r ¼ 0.926, p <
0.05). Meanwhile, its bias can be observed with Bland-Altman dia-
gram, the bias between the Self-testing INR and the conventional
method INR in parallel is (0.173  0.157) and no sample bias more
than 0.5 INR units. The median frequency of INR measurements in the
study period was 7.3 days test INR one time in PSM group compared to
38.7 days in the conventional group ( p¼0.000). Medians of the per-
centage of TTR was 68% versus 57% (p¼0.000). Cumulative risk of the
ﬁrst primary endpoint is performed by using Kaplan-Meier analysis,
P¼0.131. Thromboembolic complications occurred in 4 patients in the
PSM group versus in 15 patients in the conventional group( P¼0.277).
major bleeding events occurred in 1 patients versus 6 patients in the
PSM group and the conventional group, respectively( P¼0.534). At
least one minor bleeding occurred in two groups was no statistically
signiﬁcant ( P¼0.465). There were signiﬁcant improvement ( P¼0.038)
of the total physical score between the PSM group (42.3 5.3) and
control group (40.75.8) after 12months follow-up. Signiﬁcant
improvement was also observed in total mental composite score
(P¼0.046) in the PSM group(53.46.5) compared to control(51.5 7.2 ).
CONCLUSIONS Patient self-testing of INR has a good consistency and
stability compared with traditional laboratory testing. For the AF pa-
tients requiring chronic warfarin therapy compared with standard
treatment, the patient self-management of anticoagulation therapy is
a security and efﬁcacious choice, which could improve AF patient’s
quality of life and has a promising future application in China.
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Are 23-mm Cryoballoons Better than 28-mm Ones for the Treatment of
Atrial Fibrillation in China?
Xiongbiao Chen, Zheng Liu, Jia He, Min Tang, Jun Liu, Shu Zhang,
Pihua Fang
Department of Cardiac Arrhythmia, State Key Laboratory of
Cardiovascular Disease, Fuwai Hospital, National Center for
Cardiovascular Diseases
OBJECTIVES To compare the procedural parameters, safety and ef-
ﬁcacy between the two sizes (23- and 28- mm) of the ﬁrst-generation
cryoballoon catheter for the treatment of atrial ﬁbrillation in China.
METHODS Eighty - one consecutive patients with drug-refractory,
symptomatic AF (96.3% paroxysmal) underwent pulmonary vein
isolation (PVI) with the ﬁrst-generation CBC were enrolled. Two
groups were deﬁned according to the balloon used during each pro-
cedure: Group 23- and 28- mm. The procedural parameters, proce-
dure-related complications, acute and mid-term success rates were
compared between the two groups.
RESULTS The percentage of procedures with 23-, 28- mm balloon
alone, and double balloons was 49.4%, 46.9% and 3.7%. Compared
with Group 28- mm, the mean freeze time (41.6  9.7 vs. 32.9  3.5
min, P < 0.001), ﬂuoroscopic time (46.2  15.3 vs. 33.9  10.9 min, P <
0.001) and procedural time (125.0  27.2 vs. 98.3  18.2 min, P < 0.001)
was shorter in Group 23- mm, the acute PVI rate with CBC alone was
higher both on vein level (90.7% vs. 96.9%, P ¼ 0.021) and patient
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were isolated using either CBC alone or plus conventional radio-
frequency ablation. The AF-free survival had no signiﬁcant difference
between 23- and 28- mm groups (84.2% vs. 76.5%, P ¼ 0.726) during a
mean follow-up of 7.9  3.2 months. The complication rate was not
signiﬁcantly different between the two groups (2.5%vs.10.5%, P ¼
0.195). One case of phrenic nerve palsy was detected when froze with
a 28- mm balloon.
CONCLUSIONS CBC ablations using 23- mm balloons can simplify the
procedure, and achieve a higher acute efﬁcacy without at the cost of
safety in selected patients when compared with 28- mm ones for
catheter ablation of AF in China.
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Early Clinical Study of the Efﬁcacy and Safety of Domestic Devices for Left
Atrial Appendage Closure
Shuang Li, Dachun Xu, Dongdong Zhao, Kai Tang, Mengyun Zhu,
Wei Chen, Yawei Xu
Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji
University
OBJECTIVES Thromboembolic stroke is the most devastating compli-
cation of atrial ﬁbrillation. Occlusion of the left atrial appendage (LAA)
is believed to decrease the risk of stroke in the patients with non-
valvular atrial ﬁbrillation. LAA closure with WACTHMAN device was
authorized to prevent stroke in the patients with atrial ﬁbrillation,
replacing the traditional warfarin anticoagulants. LAmbre, a domestic
new-design double-disc LAA closure device and Lefort, a new-design
WATCHMAN-like device both entered into clinical trials, however, the
feasibility and safety should be further measured. The purpose of this
early clinical study was to determine the safety and efﬁcacy of LAA
closure using domestic LAA closure devices, the LAmbre and Lefort.
METHODS From April of 2014 to March of 2015, the patients with
atrial ﬁbrillation were enrolled to undergo percutaneous LAA closure
using the LAmbre or Lefort device. LAA closure was conﬁrmed by
transesophageal echocardiography (TEE), then TEE or transthoracic
transesophageal echocardiography (TTE) in the follow-up duration
within 7 days, at 1 month, 3 months, 6 months and 1 year post-LAA
closure. The success of sealing was deﬁned as there was no or mild
peri-device leak (jet <5mm) detected by TEE.
RESULTS Sixty-two patients were screened out to be conducted the
procedure of LAA closure using LAmbre (54 cases) and Lefore (8 cases)
respectively. Among all patients, 48 (77.4%) had permanent or
persistent atrial ﬁbrillation. The average CHADS2 score was 2.91.1
and the HAS-BLED was 3.31.0. The average time-cost of the proce-
dure was about 68 minutes. The success of LAA closure was 100%.
There were no major safety endpoint events during the peri-operative
period. The average follow-up duration was 8.6 months, of which The
LAmbre was 9.6 months, while the Lefort was 2 months. No cases lost
to follow up. The closure of LAA measured by TEE in the 3-month was
97.9%. No stroke event or device-associated severe adverse event
happened. The major SAEs were all-cause readmission (60%) and
approach-associated complications (33.3%).
CONCLUSIONS This single-center early clinical study showed the
safety and effectiveness to prevent stroke in the patients with atrial
ﬁbrillation for the procedure of LAA closure using using domestic
devices, the LAmbre or Lefort. However, further large cases and
longer follow-up visiting was still request.
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Long-term Outcome and the Mechanisms of Pulmonary Antrum
Radial-linear Ablation in Patients with Paroxysmal Atrial Fibrillation
Xue Zhao,1 Dening liao,1 Xingui Guo,2 Yawei Xu,3 Yanzhou Zhang,4
Hui Gong,5 Zhenguo Liu6
1Deparment of Cardiology, Third Afﬁliated Hospital, Second Military
Medical University; 2Department of Cardiology, Huadong Hospital,
Fudan University; 3Department of Cardiology, Shanghai Tenth People’s
Hospital, Tongji University; 4Department of Cardiology, Renji Hospital,
Shanghai Jiaotong University; 5Department of Cardiology, Jingshan
Hospital, Fudan University; 6Davis Heart & Lung Research Institute and
Division of Cardiovascular Medicine, Ohio State University Medical
Center
OBJECTIVES The aim of this study was to determine the mechanisms
and effectiveness of pulmonary antrum radial-linear (PAR) ablation in
comparison with pulmonary vein isolation (PVI) in patients with
paroxysmal atrial ﬁbrillation (AF) after a long-term follow-up.METHODS The enrollment occurred between March, 2011, and
August, 2011, with the last follow-up in May, 2014A total of 133 pa-
tients with documented paroxysmal AF were enrolled from 5 centers
and randomized to PAR group or PVI group. Event ECG recorder and
Holter monitoring were conducted during the follow-up for all
patients.
RESULTS The average procedure time was 15123 min in PAR group
and 17843 min in PVI group (P <0.001). The average ﬂuoroscopy
time was 217 min in PAR group and 2711 min in PVI group
(P ¼ 0.002). AF triggering foci were eliminated in 59 patients
(89.4%) in PAR group, whereas, only 4 patients (6.0%) in PVI group
(P <0.001). At median 36 (37-35) months of follow-up after single
ablation procedure, 43 of 66 patients in PAR group (65%) and 28 of
67 patients in PVI group (42%) had no recurrence of AF off anti-
arrhythmic drug (AAD) (P ¼0.007); and 47 of 66 patients in PAR
group (71%) and 32 of 67 patients in PVI group (48%) had no
recurrence of AF with AAD (P ¼0.006). At the last follow-up, the
burden of AF was signiﬁcantly lower in PAR group than in PVI
group (0.9%  2.3% vs 4.9%  9.9%; 90th percentile, 5.5% vs
19.6%; P ¼0.008).
CONCLUSIONS PAR ablation is a simple, safe, and effective strategy
for the treatment of paroxysmal AF with better long-term outcome
than PVI. PAR ablation might exhibit the beneﬁcial effect on AF
management through multiple mechanisms.GW26-e0725
Feasibility and Clinical Application of MSCT Three-dimensional Imaging In
Percutaneous Left Atrial Appendage Closure
Dong Yang, Zirong Wang, Zhao Xu, Tingting Yuan, Xu Wang,
Jianping Ding, Xingwei Zhang
Afﬁliated Hospital of Hangzhou Normal University, School of Medicine,
Hangzhou Normal University, Hangzhou, China
OBJECTIVES The three-dimensional(3D) structures of left atrial
appendage (LAA) in atrial ﬁbrillation patients were reconstructed by
Multi-slice computed tomography (MSCT) imaging system, aiming at
exploring the feasibility and clinical applied value in percutaneous
left atrial appendage closure.
METHODS Inclusion criteria were: voluntary patients with both
atrial ﬁbrillation and indication for LAA closure aging from 40 to 85
years old with contraindication for oral anticoagulants or unwill-
ingness to take long-term oral anticoagulation therapy. With the
three-dimensional structures of LAA which are reconstructed from
the imaging of MSCT by post-processing workstation, the measure-
ment of diameter and depth of LAA is compared between the way of
preoperatively spatial vector and postoperatively both trans-
esophageal echocardiography(TEE) and radiography, aiming at
selecting suitable size and location of LAA closure device. The de-
vices were planted at the ostium of the LAA. The TEE and (or) CT
three-dimensional reconstruction were rechecked, and follow-up of
major cardiovascular events within 3 months after implantation was
recorded.
RESULTS 17 atrial ﬁbrillation patients were enrolled (average
age:69.08.83 years old). 15 of them were non-valvular atrial ﬁbril-
lation patients [CHADS2-VAS score (3.71.78) and HAS-BLED score
(2.61.33)]. Ten of these 17 patients were successfully implanted with
the WATCHMAN LAA closure devices. Nine of the ten were with non-
valvular atrial ﬁbrillation with average CHADS2-VAS score (3.21.69)
and HAS-BLED score (2.71.63). The rest one was a valvular atrial
ﬁbrillation patient with the history of the percutaneous balloon mitral
valvuloplasty (PBMV) resulting in the lack of surgical indications of
mitral valve replacement (MVR). No blood leakage was found around
the device by regular postoperative TEE and LAA radiography exam-
inations among 10 patients. Two methods under AW4.4 system
showed high repeatability and no obvious difference with the ﬁnal
device size. There existed difference with statistical signiﬁcance
compared to TEE (All P<0.05). Thus, MSCT imaging may be superior
to the TEE. There were no complications of bleeding, embolism, or
stroke during both peri-operative period and three-month follow-up
time. Also, recheck by TEE and(or) CT 3D reconstruction three months
after procedure showed no blood leakage among 10 atrial ﬁbrillation
patients.
CONCLUSIONS Preoperative MSCT three-dimensional reconstruction
of LAA among atrial ﬁbrillation patients shows the three dimensional
structure and provides essential information guiding the successful
LAA closures. Reconstruction after the procedure provides reliable
reference for follow-up.
